Roles of extrahepatic lipolysis and the disturbance of hepatic fatty acid metabolism in TNF-α -induced hepatic steatosis
Introduction
Alcoholic liver disease (ALD) remains to be a worldwide health problem (Singal and Anand, 2013; Wang et al., 2014). ALD encompasses a spectrum of progressively aggravated liver injury ranging from steatosis, to steatohepatitis, fibrosis, and finally cirrhosis. Alcoholic fatty liver (AFL), manifested by the accumulation of triglyceride (TG) in liver, is the earliest phenotype of ALD. Epidemiological studies showed that AFL developed in about 90% of individuals who drank more than 60 g/day of ethanol, but might also occur in some sensitive individuals who drank less (O’Shea et al., 2010). Now, it is generally accepted that fatty liver is a pathogenic condition as fatty liver is more vulnerable to other hepatotoxicants such as acetaminophen and arsenic (Kucera et al., 2012; Tan et al., 2011). Notably, AFL could progress into more advanced ALD despite abstinence (Leevy, 1962; Sorensen et al., 1984). AFL is considered as the optimal intervention stage to block the progression of ALD, as steatosis is usually benign and reversible. Therefore, it has long been the research focus to elucidate the underlying mechanisms and to screen potential therapeutic agents for ethanol-induced steatosis (Zhao et al., 2017).
The pathogenesis of AFL is complicated and may be attributed to many factors including the changes of redox condition, transportation impairment of the synthesized lipid, inhibition of fatty acid oxidation, the enhancement of the lipogenesis, and the increased lipolysis of extrahepatic adipose tissue (Livero and Acco, 2016; Purohit et al., 2009; Zeng and Xie, 2009; Zhong et al., 2012). Several lines of evidence suggested that tumor necrosis factor α (TNF-α), a well-known pro-inflammatory cytokine secreted by Kupffer cells, might play some roles in the pathogenesis of AFL, which was denied by results of other studies. Ethanol-induced hepatic steatosis is accompanied by the elevation of serum and hepatic TNF-α levels (Lin et al., 1998; Pritchard et al., 2007; Zeng et al., 2016). Notably, ethanol-induced hepatic steatosis in mice could be significantly attenuated by depletion of Kupffer cell (Adachi et al., 1994; Koop et al., 1997) and by genetic knockout of TNF-α receptor 1 (TNF-R1 −/−) (Bergheim et al., 2006; Yin et al., 2001, 1999), suggesting that a causal role of TNF-α in the development of AFL. However, results of some other studies argued that TNF-α might play negligible role in AFL. For example, Ji et al. found that TNF-α made a moderate contribution to ethanol-induced elevation of alanine transaminase (ALT), necroinflammation, apoptosis, but only a small contribution to the fatty liver (Ji et al., 2004). Similarly, the study by Iimuro et al. revealed that TNF-α antibody significantly attenuated hepatic inflammation and necrosis but not steatosis (Iimuro et al., 1997). Therefore, much more work are needed to clarify the roles of TNF-α in the pathogenesis of AFL.
Our recent study showed that both Kupffer cell eliminator (GdCl3) and TNF-α receptor antagonist (etanercept, a genetically engineered, soluble, systemic TNF-α receptor fusion protein) could partially but significantly attenuate binge drinking-induced fatty liver in mice (Zhao et al., 2017). Results from both in vivo and in isolated epididymal adipose tissues showed that TNF-α could stimulate the phosphorylation of hormone sensitive lipase (HSL) and the secretion of free fatty acid (FFA), which suggested that ethanol-induced KCs activation might promote binge drinking-induced fatty liver possibly by TNF-α-mediated extrahepatic lipolysis (Zhao et al., 2017). Herein, we extended the study by directly investigating the roles of TNF-α on the hepatic fat levels in mice and in HepG2 cells and explored the potential mechanisms.
Section snippets
Materials
Human recombined TNF-α and the human TNF-α ELISA kit were obtained from Sino Biological Inc. (Beijing, China). Phenylisopropyl adenosine (PIA) and oil red o dye were purchased from Sigma (St. Louis, MO, USA). Biochemical assay kits for serum ALT, aspartate aminotransferase (AST), and triglyceride (TG) were bought from Ningbo Medical System Biotechnology Co., Ltd (Ningbo, China). Serum FFA assay kit was provided by Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Hepatic TG assay kit
TNF-α treatment did not induce TG accumulation in HepG2 cells
To investigate the roles of TNF-α on the lipid metabolism in hepatocytes and exclude the influence of extrahepatic fat metabolism, HepG2 cells were exposed to various concentrations of TNF-α for 12 h, and cellular TG levels were detected using commercial kits. Cell viability test showed that 2.5–160 ng/ml TNF-α did not significantly lead to the impairment of the cell viability (Fig. 1A). Exposure to 10–160 ng/ml TNF-α for 12 h did not induce significant increase of cellular TG levels (Fig. 1B).
Discussion
Our previous study showed that blocking TNF-α could partially attenuate binge drinking-induced liver steatosis possibly by suppressing the mobilization of white adipose tissues (Zhao et al., 2017). In the current study, we extended the study by investigating the roles of the extrahepatic lipolysis and the disturbance of hepatic lipid metabolism in TNF-α-exposed mice and also in HepG2 cells. The results showed that TNF-α led to the activation of extrahepatic lipolysis demonstrated by the
Conflict of interest
The authors declare that there are no conflicts of interest.
Transparency document
Acknowledgement
This work was supported by the National Science Foundation of China (Grant No. 81872653, 81473004), the key Research and Development Project of Shandong Province (Grant No. 2017GSF18122), and the Young Scholars Program of Shandong University (Grant No. 2015WLJH52).
References (44)
- et al.
Inactivation of Kupffer cells prevents early alcohol-induced liver injury
Hepatology
(1994) - et al.
Resveratrol alleviates alcoholic fatty liver in mice
Am. J. Physiol. Gastrointest. Liver Physiol.
(2008) - et al.
Metformin prevents alcohol-induced liver injury in the mouse: critical role of plasminogen activator inhibitor-1
Gastroenterology
(2006) - et al.
Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha
Alcohol
(2004) - et al.
Effect of N6-(L-2-phenylisopropyl)adenosine and insulin on cAMP metabolism in 3T3-L1 adipocytes
Am. J. Physiol.
(1987) - et al.
TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c)
Exp. Biol. Med. (Maywood)
(2007) - et al.
Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production
Am. J. Physiol.
(1990) - et al.
Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice
J. Biol. Chem.
(2003) - et al.
Regulation of adipocyte lipolysis
Nutr. Res. Rev.
(2014) - et al.
Tumor necrosis factor alpha stimulates lipolysis in adipocytes by decreasing Gi protein concentrations
J. Biol. Chem.
(1999)
Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway
J. Biol. Chem.
Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat
Hepatology
Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model
J. Hepatol.
Role of TNF-alpha in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury
Hepatology
Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity
Chem. Biol. Interact.
Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intragastric alcohol despite the induction of CYP2E1
Mol. Pharmacol.
Susceptibility of rat non-alcoholic fatty liver to the acute toxic effect of acetaminophen
J. Gastroenterol. Hepatol.
Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature
Medicine
Chronic ethanol consumption induces the production of tumor necrosis factor-alpha and related cytokines in liver and adipose tissue
Alcohol. Clin. Exp. Res.
Molecular basis of alcoholic fatty liver disease: from incidence to treatment
Hepatol. Res.
Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation
J. Pharmacol. Exp. Ther.
Alcoholic liver disease
Hepatology
Cited by (0)
- 1
These authors contributed equally to the work.